Report #2877993

Received Dec 15, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: —
Recovered: Unknown
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
COVID19	COVID19 (COVID19 (PFIZER-BIONTECH))	PFIZER\BIONTECH	1	—	—

Symptoms (1)

Temporomandibular pain and dysfunction syndrome

Symptom narrative

Latuda was not too bad but I think it was starting to get me a little bit of a TMJ; This is a spontaneous report received from a Consumer or other non HCP. A patient (age and gender not provided) received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation; lurasidone hydrochloride (LATUDA). The patient's relevant medical history and concomitant medications were not reported. The following information was reported: TEMPOROMANDIBULAR PAIN AND DYSFUNCTION SYNDROME (non-serious), outcome "unknown", described as "Latuda was not too bad but I think it was starting to get me a little bit of a TMJ". The action taken for lurasidone hydrochloride was unknown. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.

Other medications

LATUDA